Giving Hope and Time
Dear Friends:

Happy Spring!

I'm sharing great news and I hope to leave you with a sense of the legacy you have helped to build for our patients, their families, future generations, future cancer treatments and access to them.

The stories featured in this letter are only possible because you've supported this foundation. The side effects of your support are time, hope and life.

Case in point - this photo is from a very recent visit with former LCF patient Michael and his wife Kasey. Michael was told he most likely would have cancer for the rest of his life and that he should expect to be on one drug or another. But he responded well to his clinical trial treatment and, as a result, has been cancer free since 2012!

Enjoy the beauty of this season and know that we count you among our many blessings.

Warmest Regards,
KA Signature tiny
Karen Ambrogi, Communications Manager
UCSF Study Aims to Increase Diversity in Cancer Clinical Trials
Collaboration with Lazarex Cancer Foundation Tests New Ways to Erase Cost Barriers in Major Public Health Issue

By Elizabeth Fernandez

April 15, 2019: UC San Francisco is collaborating with the nonprofit Lazarex Cancer Foundation on a three-year study to identify ways to improve cancer clinical trial participation among medically underserved populations, including low-income individuals and racial and ethnic minorities. 

The trial will launch this month at UCSF, followed by the University of Southern California and then rolling out to other sites nationwide. 

February 21, 2019: A symposium and reception was held at the UCSF campus to celebrate the pending April launch of the IMPACT Study.

Pictured above from L-R: Hala Borno MD (UCSF), Lordes Baezconde-Garbanati PhD, MPH (USC), Darcy Spicer, MD (USC), Dana Dornsife (Lazarex); Robert Johnson Jr., MD, PhD (Lazarex), Alan Ashworth, PhD, FRS (UCSF).
Very Important Patient Updates:
Cindy's Story

Cindy Schlager, a Lazarex patient, is "Still Here" after being diagnosed with anal cancer in 2015 and given 6-12 months to live. Lazarex Cancer Foundation has been assisting Cindy with the hefty costs to travel frequently from her home in Colorado to her clinical trial treatment at MD Anderson in Texas. This CBS4 Denver news video sums up  why   we do  what   we do and how your support translates to months and years of life for patients with advanced stage cancer.

 Watch the  CBS4 Denver news story  
featuring Cindy and Lazarex to learn more. 

Please Welcome Babette Stewart to Our Team
Babette Stewart recently joined Lazarex as our Financial Manager. She is a 25 - year Danville resident and her most treasured role is as the mother of her one and only daughter and of her furry baby, a mini Australian Shepherd.   

Babette is a cancer survivor and considers it a a blessing that her work with Lazarex is helping others with a struggle that she understands from a personal perspective.  
5.44K Prices Increase for "Day Of" Registration
Prices increase on April 27, the day of the Lazarex IMPACT 5.44K
Save yourself $5 per person or pet when you register by 11:59 PM Friday, April 26th.
5.44K in Danville: Meet at the Lazarex office. Kids & pets are welcome! We'll complete a distance of 5.44K (3.38 miles) through the town of Danville. Pick up your bib and t-shirt at the Lazarex office, Friday April 26th between 10:00 am and 2:00 pm or, on the day of the event when you check in. 

EVENT TIME : Check In 7:30 am Start 9:00 am Finish 11:00 am
START & FINISH :  50 Oak Court, Danville, CA 94526 (Lazarex office)
WHEN: Saturday, April 27, 2019 9:00 AM (PST)
Lazarex Fun Fact
Our small but mighty 8 member Big Sur International Marathon team is on track to raise over $20,500 to help cancer patients get to their clinical trial treatments!

Best wished to our team on April 28th! Have a blast and finish strong!
About Lazarex Cancer Foundation

We improve the outcome of cancer care, giving hope, dignity and life to advanced stage cancer patients and the medically underserved by providing assistance with costs for FDA clinical trial participation, navigation through clinical trial options, community outreach and engagement. To learn more, please contact us at 925.820.4517, toll-free at 877.866.9523, or visit us at .